Compass Pathways Plc ADR
Închisă
12.49 -1.26
Rezumat
Modificarea prețului
24h
Minim
12.33
Maxim
13.48
Venit | 185M 91M |
|---|---|
EPS | -0.3 |
Angajați | 156 |
EBITDA | 139M 93M |
Recomandări | Puternic Cumpărare |
|---|---|
Prognoză pe 12 luni | +85.77% upside |
Următoarele câștiguri | 30 iul. 2026 |
|---|
Capitalizare de piață | 428M 1.7B |
|---|---|
Deschiderea anterioară | 13.75 |
Închiderea anterioară | 12.49 |
Compass Pathways Plc ADR Grafic
Performanțele din trecut nu reprezintă un indicator fiabil al rezultatelor viitoare.
Despre Compass Pathways Plc ADR
COMPASS Pathways plc operates as a mental health care company in the United Kingdom and the United States. It develops COMP360, a psilocybin therapy that is in Phase III clinical trials for the treatment of treatment-resistant depression; and is in Phase II clinical trials for the treatment of post-traumatic stress disorder and anorexia nervosa. The company was formerly known as COMPASS Rx Limited and changed its name to COMPASS Pathways plc in August 2020. COMPASS Pathways plc was incorporated in 2020 and is headquartered in London, the United Kingdom.
